Correction to: Fremanezumab: First Global Approval

被引：0

|

作者：

Sheridan M. Hoy

机构：

[1] Springer,

来源：

Drugs | 2019年 / 79卷 / 5期

关键词：

D O I：

10.1007/s40265-019-01088-y

中图分类号：

学科分类号：

摘要：

The original article can be found online.

引用

收藏

页码：585 / 585

相关论文

共 50 条

[31] Correction to: Lenacapavir: First Approval
Julia Paik
[J]. Drugs, 2023, 83 (11) : 1061 - 1061
[32] Correction to: Efgartigimod: First Approval
Young-A Heo
[J]. Drugs, 2022, 82 (5) : 611 - 611
[33] Correction to: Motixafortide: First Approval
Sheridan M. Hoy
[J]. Drugs, 2023, 83 (18) : 1737 - 1737
[34] Correction to: Fostemsavir: First Approval
Anthony Markham
[J]. Drugs, 2020, 80 (15) : 1615 - 1615
[35] Correction to: Zavegepant: First Approval
Sohita Dhillon
[J]. Drugs, 2023, 83 (11) : 1063 - 1063
[36] Correction to: Ubrogepant: First Approval
Lesley J. Scott
[J]. Drugs, 2020, 80 (5) : 523 - 523
[37] Correction to: Regdanvimab: First Approval
Yahiya Y. Syed
[J]. Drugs, 2021, 81 (18) : 2139 - 2139
[38] Correction to: Satralizumab: First Approval
Young-A Heo
[J]. Drugs, 2020, 80 (14) : 1483 - 1483
[39] Correction: Elacestrant: First Approval
Sheridan M. Hoy
[J]. Drugs, 2023, 83 (18) : 1735 - 1735
[40] Correction to: Pexidartinib: First Approval
Yvette N. Lamb
[J]. Drugs, 2020, 80 (4) : 447 - 447

← 1 2 3 4 5 →